Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Derma Sciences Inc. (DSCI)’

Jeff Smith

Starboard Trims Office Depot Stake Amid FTC Challenging Merger with Staples; Broadfin Capital Buys More Derma Sciences Inc. (DSCI)

Some bright minds of the finance world believe that shareholder activism has surged in recent years because of increased market efficiency. Hedge funds......(read more)
SunEdison SUNE Solar Panels

Why Are These Five Stocks Plunging on Thursday?

Despite today’s healthy jobless claims report, the stock market has inched down since the bell, with the shares of Sunedison Inc (NYSE:SUNE), Freeport......(read more)
Broadfin Kevin Kotler

Broadfin Buffs Up on Zogenix, Inc. (ZGNX) and Derma Sciences Inc (DSCI)

In two separate filings today Kevin Kotler‘s Broadfin Capital has revealed increasing its passive stake in Zogenix, Inc. (NASDAQ:ZGNX) to 10.74......(read more)
Great_Point_Partners_Llc_1091900

Connecture Inc (CNXR), Hyperion Therapeutics Inc (HPTX): Top 5 Healthcare Picks of Great Point Partners

Jeffrey Jay and David Kroin’s Great Point Partners is one of the newer funds we track at Insider Monkey, and we’ll cover the healthcare-focused fund......(read more)
Broadfin Kevin Kotler

Kevin Kotler’s Broadfin Capital Initiates Stake in Eleven Biotherapeutics (EBIO) Following Its IPO

Broadfin Capital, led by Kevin Kotler, in a filing with the Securities and Exchange Commission, reported initiating a position in Eleven Biotherapeutics......(read more)
Broadfin Kevin Kotler

Broadfin Capital Initiates a Stake in Retrophin Inc (RTRX) Following Its Listing on NASDAQ

Kevin Kotler’s Broadfin Capital has revealed a new stake in Retrophin Inc (NASDAQ:RTRX), which amasses 6.93% of the company’s common stock, it contains......(read more)
Peter Kolchinsky

Ra Capital Management Lowers Stake in Derma Sciences Inc (DSCI)

Peter Kolchinsky‘s Ra Capital Management has recently sold a total of 300,000 shares of Derma Sciences Inc (NASDAQ:DSCI). Following the disposal......(read more)
Broadfin Kevin Kotler

Broadfin Capital Ups Position in Rigel Pharmaceuticals, Inc. (RIGL)

Kevin Kotler‘s Broadfin Capital increased its exposure to Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), a filing with the SEC showed. Broadfin reported......(read more)
BLUE RIDGE CAPITAL

5 Stocks Hedge Funds Bought Recently

Academic research on hedge funds have shown that the stocks bought by hedge funds outperform the market on average. In this article we will focus on 5......(read more)
Broadfin Kevin Kotler

Kevin Kotler, Broadfin Capital Raise Holding in Derma Sciences Inc (DSCI)

Kevin Kotler‘s Broadfin Capital has increased its position in Derma Sciences Inc (NASDAQ:DSCI). According to a new filing with the SEC, Broadfin......(read more)
Osiris Therapeutics, Inc.

Osiris Therapeutics, Inc. (OSIR), Derma Sciences Inc (DSCI): The Changing Landscape in Chronic Diabetic Foot Ulcers

While the market of treating chronic diabetic foot ulcers is by no means glamorous, it can still be a very lucrative indication. Some estimates have put......(read more)
Harvard Bioscience Inc. (HBIO)

Hedge Funds Are Buying Harvard Bioscience, Inc. (HBIO)

Harvard Bioscience, Inc. (NASDAQ:HBIO) was in 8 hedge funds’ portfolio at the end of March. HBIO shareholders have witnessed an increase in activity......(read more)

AtriCure Inc. (ATRC): Are Hedge Funds Right About This Stock?

AtriCure Inc. (NASDAQ:ATRC) has experienced an increase in enthusiasm from smart money of late. In today’s marketplace, there are tons of indicators......(read more)
Raj Rajaratnam thinking

Man Appoints Hendricks, Raj Seeks Appeal, Powerball Controversy

Man Group Appoints Hendriks as Institutional Head (HFMWeek) Man Group, the world’s largest listed fund manager, has appointed ex-Goldman Sachs man Ruud......(read more)
Peter Kolchinsky

Raging Capital Took Activist Stake in Derma Sciences

Raging Capital filed on November 29th for its 13.5% activist stake in Derma Sciences, Inc. (DSCI). Raging Capital is one of DSCI’s insider. According......(read more)